Whilst our pilot study in an Australian White population that explored a more comprehensive panel of immune and pain-related SNPs revealed risk of severe GI adverse effects after 5-FU was related to TNF and toll-like receptor 2 (TLR2) SNPs, together with cancer type, a non-genetic predictor [11]. Here, TLR2 is linked to cancer.